Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Source: SeekingAlpha
2026-01-15 12:55:57 ET
Precigen, Inc. (PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST...
Read the full article on Seeking Alpha
For further details see:
Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Precigen Inc.
NASDAQ: PGEN
PGEN Trading
2.16% G/L:
$3.55 Last:
43,439 Volume:
$3.55 Open:
PGEN Latest News
March 11, 2026 04:05:00 pm
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25
January 20, 2026 08:05:00 am
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
January 12, 2026 08:00:00 am
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026 04:05:00 pm
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
PGEN Stock Data
$1,632,900,063
187,173,160
1.3%
60
N/A
Biotechnology & Life Sciences
Healthcare
US
Germantown
